Schedule 13G ownership disclosure

Tenax Therapeutics, Inc.

Common Stock, $0.0001 par value per share · CUSIP: 88032L605

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RTW Investments, LP

    Shares: 418,440 · Class: 9.99%

  • Roderick Wong, M.D.

    Shares: 418,440 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-072034
Form type
SCHEDULE 13G
Filer
RTW INVESTMENTS, LP
CIK
CIK 1493215
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub